Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones  J. Mensa, A. Trilla 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Detection of Fusobacterium necrophorum subsp
Patterns of delays in diagnosis amongst patients with smear-positive pulmonary tuberculosis at a teaching hospital in Turkey  E. Okur, A. Yilmaz, A. Saygi,
Rapid streptococcal testing for sore throat and antibiotic resistance
L. Boyanova  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics  Y.H. van Beurden, S. Nezami,
J. Ambrosioni, A. Mamin, A. Hadengue, M. Bernimoulin, K. Samii, C
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Rapid streptococcal testing for sore throat and antibiotic resistance
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Non-antibiotic strategies for sepsis
P. Davey, C. Pagliari, A. Hayes  Clinical Microbiology and Infection 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Training for the infectious diseases speciality in Norway
G. Höffken  Clinical Microbiology and Infection 
Community-acquired pneumonia: the evolving challenge
J. Du, X. Wang, Y. Hu, Z. Li, Y. Li, S. Sun, F. Yang, Q. Jin 
Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever?  S. Edouard, A. Michel-Lepage, D. Raoult 
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples  G.B. Rogers, P. Marsh, A.F. Stressmann, C.E. Allen,
Elements of design: the knowledge on which we build
W. van den Bijllaardt, I.T. Overdevest, A.G. Buiting, J.J. Verweij 
J. S. Oxford, S. Bossuyt, S. Balasingam, A. Mann, P. Novelli, R
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
U. Sagel, R.T. Mikolajczyk, A. Krämer 
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Benchmarking inappropriate empirical antibiotic treatment
Current experience in treating invasive zygomycosis with posaconazole
Reducing antibiotic use in influenza: challenges and rewards
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Microbiologic factors affecting Clostridium difficile recurrence
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study 
Abstracts Clinical Microbiology and Infection
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Community-acquired acute bacterial meningitis in the elderly in Turkey
Impact of antibiotic restrictions: the patient's perspective
Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis  Bernard Grenier  Clinical.
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones  J. Mensa, A. Trilla  Clinical Microbiology and Infection  Volume 12, Pages 42-54 (January 2006) DOI: 10.1111/j.1469-0691.2006.01396.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Development of the ‘Vicious Cycle'. Clinical Microbiology and Infection 2006 12, 42-54DOI: (10.1111/j.1469-0691.2006.01396.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Sequence of events leading to the start of the VC in patients with CB: A patient with CB start from point A, where the bacterial load (left axis), and therefore the degree of purulent sputum (right axis) is low, as represented by the A’ point, due to a mild impairment of the mucocilliary drainage system. Once a cause for the acute exacerbation is present, the drainage system is hampered, and patient's status can move to B point, which corresponds to a B’ level of bacterial load and purulent sputum. If the B’ point is close to or above the threshold level (> 106 cfu/ml bacterial density), the Vicious Cycle can start (see text). Adequate antibiotic treatment can reduce the degree of bacterial load, moving the patient down to point A'. Clinical Microbiology and Infection 2006 12, 42-54DOI: (10.1111/j.1469-0691.2006.01396.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions